Boston Scientific scores 2 regulatory wins for embolization device

11/20/2013 | BioSpectrum Asia

The Direxion Torqueable Microcatheter, developed by Boston Scientific, has won FDA clearance and CE Mark approval in Europe. The device is designed to help interventional radiologists perform peripheral embolization procedures meant to treat patients with uterine fibroids, liver cancer and other conditions.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN